Stay updated with breaking news from Nasdaq Phvs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharvaris (NASDAQ:PHVS – Get Free Report) was the recipient of a significant decrease in short interest in June. As of June 30th, there was short interest totalling 18,900 shares, a decrease of 47.6% from the June 15th total of 36,100 shares. Approximately 0.2% of the company’s stock are short sold. Based on an average trading […]
Pharvaris (NASDAQ:PHVS – Free Report) was the target of a large drop in short interest during the month of June. As of June 15th, there was short interest totalling 36,100 shares, a drop of 44.4% from the May 31st total of 64,900 shares. Based on an average daily volume of 28,900 shares, the short-interest ratio […]
ZUG, Switzerland, June 20, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company focused on the development and commercialization...
Pharvaris (NASDAQ:PHVS – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. The average […]
Pharvaris (NASDAQ:PHVS – Get Rating) has been given an average recommendation of “Moderate Buy” by the six analysts that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have given a buy recommendation to the company. The average […]